News

Press ReleaseCell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturing
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Collaboration recommends how to improve patient referral pathways for gene therapiesCollaboration recommends how to improve patient referral pathways for gene therapiesCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandSelecting appropriate models for non-clinical studies of gene therapiesSelecting appropriate models for non-clinical studies of gene therapiesRegulatory Round-up - August 2023Regulatory Round-up - August 2023Cell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesRegulatory Round-up - July 2023Regulatory Round-up - July 2023Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyThe Advanced Therapies Apprenticeship Community welcomes its 300th apprenticeThe Advanced Therapies Apprenticeship Community welcomes its 300th apprenticeRegulatory Round-up - June 2023Regulatory Round-up - June 2023